Stay updated on Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial page.

Latest updates to the Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added; the previous v3.4.1 notice about government funding and operating status was removed.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about government funding lapses was added, and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedAdds a 'Show glossary' option, updates labels such as 'Last Update Submitted that Met QC Criteria', adds 'No FEAR Act Data', and displays a new 'Revision: v3.4.0'; removes the older lowercase/case variants and the previous revision label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedFooter revision label updated from v3.3.3 to v3.3.4; no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a broader list of study locations by state (Alabama, California, Colorado, Connecticut, District of Columbia, Georgia, Illinois, Louisiana, Maryland, Massachusetts, Michigan, Nebraska, New Jersey, New York, Ohio, Oklahoma, Pennsylvania, Tennessee, Texas) and updated the revision to v3.3.3; removed the previous list corresponding to v3.3.2.SummaryDifference2%

- Check85 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial page.